California Institute for Regenerative Medicine

First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder

The California Institute for Regenerative Medicine (CIRM) celebrates a major milestone in the agency’s 21-year history: the first approved therapy to come out of California taxpayer funding. The U.S.
cirm.ca.gov

Public Meetings

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
cirm.ca.gov

T-Cell Therapy (ECT204) in Adults With Advanced HCC

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
cirm.ca.gov

Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells.

The ability to accurately and reproducibly measure stem cell activity is important for success of cellular therapies. A panel of potency assays that measures activities of stem cell functions related ...
cirm.ca.gov

CIRM announces Tools and Technologies Grants to remove obstacles on the path to therapies

Irvine, Calif., December, 10, 2008 – The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, will be funding 23 grants to 18 institutions aimed at generating new tools ...
cirm.ca.gov

CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials

South San Francisco, CA, December 11, 2025 – The California Institute for Regenerative Medicine (CIRM) governing board today approved funding of over $160 million for 16 new research awards to develop ...
cirm.ca.gov

CIRM funds clinical research in heart failure and cystic fibrosis, supports 10 new translational projects

South San Francisco, CA, May 30, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded $53 million ...
cirm.ca.gov

CIRM invests more than $42 million in translational-stage research

South San Francisco, CA, Oct. 27, 2023– The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $42.1 million to fund ...
cirm.ca.gov

CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development

South San Francisco, CA, March 27, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, approved new and ...
cirm.ca.gov

CIRM Appoints New CEO

South San Francisco, CA, July 9, 2024 – The Independent Citizens’ Oversight Committee (ICOC), the governing board of the California Institute for Regenerative Medicine (CIRM), is pleased to announce ...
cirm.ca.gov

CIRM approves $73 million in awards for discovery research

South San Francisco, CA, September 25, 2025 – The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million across 23 grants to support discovery research ...
cirm.ca.gov

Research Training Grant

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate stem cell treatments to patients with unmet medical needs. The overall objective of the CIRM Research Training ...